SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Dec-20 4:06 PM View: | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 7,500 | -- | -- | 143% 5.25K to 12.75K | |
08-Jun-20 4:12 PM View: | Cellectar Biosciences, Inc. (CLRB) | 04-Jun-20 | Market Purchase | 18,000 | $1.08 | $19,438.20 | 100% 0 to 18.0K | 89% |
30-Nov-18 6:19 PM View: | Cellectar Biosciences, Inc. (CLRB) | 29-Nov-18 | Market Sale | 992 | $2.21 | $2,192.41 | (100%) 0.99K to 0 | 9% |
06-Sep-18 9:41 PM View: | Targacept, Inc. (GYRE) | 06-Sep-18 | Disposition | 190 | $10.07 | $1,913.30 | (14%) 1.38K to 1.19K | 57% |
02-Jan-18 6:15 PM View: | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 2,500 | -- | -- | 62% 4.0K to 6.5K | |
02-Jan-18 6:15 PM View: | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 1,250 | $3.47 | $4,341.50 | (19%) 6.5K to 5.25K | 51% |
21-Apr-16 6:04 PM View: | Cellectar Biosciences, Inc. (CLRB) | 20-Apr-16 | Market Purchase | 9,390 | $2.12 | $19,906.80 | 1772% 0.53K to 9.92K | (88%) |
18-Dec-15 5:42 PM View: | Targacept, Inc. (GYRE) | 17-Dec-15 | Market Purchase | 5,000 | $2.03 | $10,150.00 | 32% 15.71K to 20.71K | (86%) |
31-Aug-15 3:55 PM View: | Targacept, Inc. (GYRE) | 28-Aug-15 | Payment of Exercise | 12,146 | $6.72 | $81,621.10 | (44%) 27.86K to 15.71K | |
13-Nov-14 10:00 PM View: | Lipocine Inc. (LPCN) | 13-Nov-14 | Market Purchase | 4,000 | $4.95 | $19,799.60 | 100% 0 to 4.0K | (66%) |
21-Oct-14 4:21 PM View: | Targacept, Inc. (GYRE) | 17-Oct-14 | Grant | 175,000 | -- | -- | 875% 20.0K to 195.0K | |
22-Aug-14 4:37 PM View: | Cellectar Biosciences, Inc. (CLRB) | 20-Aug-14 | Purchase | 5,300 | $3.75 | $19,875.00 | 100% 0 to 5.3K | |
11-Mar-13 4:33 PM View: | Targacept, Inc. (GYRE) | 11-Mar-13 | Market Purchase | 10,000 | $4.38 | $43,781.00 | 100% 10.0K to 20.0K | (99%) |
11-Mar-13 4:33 PM View: | Targacept, Inc. (GYRE) | 08-Mar-13 | Market Purchase | 10,000 | $4.48 | $44,796.00 | 100% 0 to 10.0K | (99%) |